Back to search results

Randomised Trial of Induction Gemcitabine and Cisplatin Versus Gemcitabine, Cisplatin, Pembrolizumab and Bevacizumab (GPPB) in Nasopharyngeal Cancer

Abroad (travel likely)RecruitingPHASE2

Conditions

Nasopharyngeal Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • National University Hospital, Singapore, Singapore

    Contact: Study coordinator (Wan Qin Chong, MBBS, MRCP, MMed) · wan_qin_chong@nuhs.edu.sg · 6772 4614
    Contact: Principal Investigator (Wan Qin Chong)
    Boon Cher Goh (Sub-investigator)
    Ross Soo (Sub-investigator)
    Robert John Walsh (Sub-investigator)
    Rachel Wong (Sub-investigator)
    Kenneth Sooi (Sub-investigator)
    Silvana Wijaya (Sub-investigator)
    Jerold Low (Sub-investigator)
    Joshua Tay (Sub-investigator)
    Donovan Eu (Sub-investigator)
View source on ClinicalTrials.gov(opens in a new tab)